USFDA completes audit at Dr. Reddy's Lab’s Srikakulam plant

29 Jan 2020 Evaluate

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy's Laboratories manufacturing plant at Srikakulam, Andhra Pradesh (CTO VI). The audit completed on January 28, 2020. After the audit, the company has been issued Form 483 with 5 observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1175.55 -10.90 (-0.92%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×